The French Innothera Holding plans to start production of its medicines in Russia, as reported by Arnaud Gobet, the Holding President, at a press briefing held on May 23 in the ARTPLAY Center. It is assumed that this step will increase the production of the most relevant preparations of the Company for gynecology (Polygynax, Pharmatex), hematology (Totema), phlebology (Phlebodia 600) and other areas of medicine. The Company management has already held a number of meetings with potential partners.

31 May 2017

Investor profile



Company's website:

T: +33 (0) 1 46 15 18 00

A private company

Contact: Arnaud Gobet, President

The INNOTHERA Group is widely represented both in France and abroad. The INNOTHERA’s products are supplied to more than 100 countries around the world.